Douglas Drager

530 citations
7 papers · 317 indexed · h-index 6
Topics
Hemophilia Treatment and Research (6 papers)Platelet Disorders and Treatments (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
Partner nations
United StatesFranceItaly

In The Last Decade

Douglas Drager

7 papers receiving 310 citations

Peers

Douglas Drager
Comparison fields: 5 of 38
  • Hematology 180
  • Molecular Biology 147
  • Genetics 97
  • Oncology 51
  • Radiology, Nuclear Medicine and Imaging 48
Replace Erin Burnett with:
Erin Burnett Canada
Alvin Luk China
Mariëtte Boon‐Spijker Netherlands
H.H. Brackmann Germany
Karen L. Tubridy United States
Nathalie Enjolras France
Erin L. Kuether United States
Christina Hausl Austria
Bagirath Gangadharan United States
Christina Kober Germany
Douglas Drager relative to Erin Burnett Canada Erin Burnett's profile →
Citations per field
00.5×10×12.7×
Erin Burnett · 1×
Citations per year

Countries citing papers authored by Douglas Drager

Since Specialization
Citations

This map shows the geographic impact of Douglas Drager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Drager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Drager more than expected).

Fields of papers citing papers by Douglas Drager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Drager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Drager. The network helps show where Douglas Drager may publish in the future.

Co-authorship network of co-authors of Douglas Drager

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Drager. A scholar is included among the top collaborators of Douglas Drager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Drager. Douglas Drager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 26
2 91
3 54
4 21
5 9
6 115
7 1

About Douglas Drager

Douglas Drager is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 7 papers that have together received 317 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (180 citations), Genetics (97 citations) and Genetics (34 citations). Douglas Drager has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Tongyao Liu, Haiyan Jiang, Susannah Patarroyo‐White, Glenn F. Pierce, Robert Peters, Justin T. McCue, Elizabeth P. Merricks, Paul Sakorafas, Jennifer Dumont and Timothy C. Nichols. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026